nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—Cytochrome P450 2C9 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.553	1	CiPCiCtD
Zafirlukast—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0136	0.0399	CbGbCtD
Zafirlukast—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0123	0.0361	CbGbCtD
Zafirlukast—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0123	0.0361	CbGbCtD
Zafirlukast—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0118	0.0346	CbGbCtD
Zafirlukast—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.00912	0.0268	CbGbCtD
Zafirlukast—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.00877	0.0257	CbGbCtD
Zafirlukast—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00865	0.0254	CbGbCtD
Zafirlukast—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00865	0.0254	CbGbCtD
Zafirlukast—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00853	0.025	CbGbCtD
Zafirlukast—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00802	0.0235	CbGbCtD
Zafirlukast—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00787	0.0231	CbGbCtD
Zafirlukast—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0074	0.0217	CbGbCtD
Zafirlukast—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0074	0.0217	CbGbCtD
Zafirlukast—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00725	0.0213	CbGbCtD
Zafirlukast—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00725	0.0213	CbGbCtD
Zafirlukast—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00709	0.0208	CbGbCtD
Zafirlukast—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00669	0.0196	CbGbCtD
Zafirlukast—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00667	0.0196	CbGbCtD
Zafirlukast—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00667	0.0196	CbGbCtD
Zafirlukast—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00655	0.0192	CbGbCtD
Zafirlukast—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00655	0.0192	CbGbCtD
Zafirlukast—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00649	0.019	CbGbCtD
Zafirlukast—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00628	0.0184	CbGbCtD
Zafirlukast—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00626	0.0184	CbGbCtD
Zafirlukast—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0061	0.0179	CbGbCtD
Zafirlukast—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0061	0.0179	CbGbCtD
Zafirlukast—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00608	0.0178	CbGbCtD
Zafirlukast—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00603	0.0177	CbGbCtD
Zafirlukast—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00603	0.0177	CbGbCtD
Zafirlukast—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00561	0.0165	CbGbCtD
Zafirlukast—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00552	0.0162	CbGbCtD
Zafirlukast—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00552	0.0162	CbGbCtD
Zafirlukast—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0055	0.0161	CbGbCtD
Zafirlukast—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0055	0.0161	CbGbCtD
Zafirlukast—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00527	0.0155	CbGbCtD
Zafirlukast—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00521	0.0153	CbGbCtD
Zafirlukast—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00507	0.0149	CbGbCtD
Zafirlukast—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00505	0.0148	CbGbCtD
Zafirlukast—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00476	0.014	CbGbCtD
Zafirlukast—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00462	0.0136	CbGbCtD
Zafirlukast—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00457	0.0134	CbGbCtD
Zafirlukast—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00457	0.0134	CbGbCtD
Zafirlukast—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00438	0.0129	CbGbCtD
Zafirlukast—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00418	0.0123	CbGbCtD
Zafirlukast—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00418	0.0123	CbGbCtD
Zafirlukast—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00412	0.0121	CbGbCtD
Zafirlukast—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00388	0.0114	CbGbCtD
Zafirlukast—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00388	0.0114	CbGbCtD
Zafirlukast—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00351	0.0103	CbGbCtD
Zafirlukast—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00351	0.0103	CbGbCtD
Zafirlukast—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00303	0.00888	CbGbCtD
Zafirlukast—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00294	0.00862	CbGbCtD
Zafirlukast—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00266	0.0078	CbGbCtD
Zafirlukast—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00266	0.0078	CbGbCtD
Zafirlukast—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00255	0.00748	CbGbCtD
Zafirlukast—CYSLTR2—lung—acquired immunodeficiency syndrome	0.00149	0.0866	CbGeAlD
Zafirlukast—CYSLTR1—lymphoid tissue—acquired immunodeficiency syndrome	0.000682	0.0395	CbGeAlD
Zafirlukast—CYSLTR1—blood—acquired immunodeficiency syndrome	0.000642	0.0372	CbGeAlD
Zafirlukast—CYSLTR1—bone marrow—acquired immunodeficiency syndrome	0.000621	0.036	CbGeAlD
Zafirlukast—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000602	0.0349	CbGeAlD
Zafirlukast—CYSLTR1—vagina—acquired immunodeficiency syndrome	0.000595	0.0345	CbGeAlD
Zafirlukast—CYSLTR1—lung—acquired immunodeficiency syndrome	0.000563	0.0326	CbGeAlD
Zafirlukast—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000525	0.0304	CbGeAlD
Zafirlukast—CYSLTR1—nervous system—acquired immunodeficiency syndrome	0.000521	0.0302	CbGeAlD
Zafirlukast—CYSLTR1—central nervous system—acquired immunodeficiency syndrome	0.000502	0.0291	CbGeAlD
Zafirlukast—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000492	0.0285	CbGeAlD
Zafirlukast—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00048	0.0278	CbGeAlD
Zafirlukast—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000467	0.027	CbGeAlD
Zafirlukast—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000442	0.0256	CbGeAlD
Zafirlukast—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000426	0.0247	CbGeAlD
Zafirlukast—CYSLTR1—brain—acquired immunodeficiency syndrome	0.000398	0.0231	CbGeAlD
Zafirlukast—CYSLTR1—lymph node—acquired immunodeficiency syndrome	0.000385	0.0223	CbGeAlD
Zafirlukast—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000356	0.0206	CbGeAlD
Zafirlukast—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00035	0.0203	CbGeAlD
Zafirlukast—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000231	0.0134	CbGeAlD
Zafirlukast—CYP2C19—blood—acquired immunodeficiency syndrome	0.00022	0.0128	CbGeAlD
Zafirlukast—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000205	0.0119	CbGeAlD
Zafirlukast—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000204	0.0118	CbGeAlD
Zafirlukast—CYP2C8—blood—acquired immunodeficiency syndrome	0.000192	0.0111	CbGeAlD
Zafirlukast—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000189	0.011	CbGeAlD
Zafirlukast—ABCG2—blood—acquired immunodeficiency syndrome	0.000187	0.0108	CbGeAlD
Zafirlukast—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000181	0.0105	CbGeAlD
Zafirlukast—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.00018	0.0104	CbGeAlD
Zafirlukast—CYP1A2—blood—acquired immunodeficiency syndrome	0.00018	0.0104	CbGeAlD
Zafirlukast—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000179	0.0104	CbGeAlD
Zafirlukast—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000178	0.0103	CbGeAlD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000175	0.0446	CbGpPWpGaD
Zafirlukast—ABCG2—vagina—acquired immunodeficiency syndrome	0.000173	0.01	CbGeAlD
Zafirlukast—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000172	0.00997	CbGeAlD
Zafirlukast—CYP2C9—blood—acquired immunodeficiency syndrome	0.000171	0.0099	CbGeAlD
Zafirlukast—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.00017	0.00985	CbGeAlD
Zafirlukast—ABCG2—lung—acquired immunodeficiency syndrome	0.000164	0.0095	CbGeAlD
Zafirlukast—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000164	0.00949	CbGeAlD
Zafirlukast—CYP2E1—blood—acquired immunodeficiency syndrome	0.000162	0.00938	CbGeAlD
Zafirlukast—CYP1A2—lung—acquired immunodeficiency syndrome	0.000158	0.00915	CbGeAlD
Zafirlukast—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000156	0.00904	CbGeAlD
Zafirlukast—PTGS1—blood—acquired immunodeficiency syndrome	0.000156	0.00904	CbGeAlD
Zafirlukast—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.00015	0.00871	CbGeAlD
Zafirlukast—PTGS1—vagina—acquired immunodeficiency syndrome	0.000145	0.00838	CbGeAlD
Zafirlukast—CYP2E1—lung—acquired immunodeficiency syndrome	0.000142	0.00823	CbGeAlD
Zafirlukast—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000137	0.00793	CbGeAlD
Zafirlukast—PTGS1—lung—acquired immunodeficiency syndrome	0.000137	0.00793	CbGeAlD
Zafirlukast—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000135	0.0078	CbGeAlD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000133	0.0339	CbGpPWpGaD
Zafirlukast—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000132	0.00762	CbGeAlD
Zafirlukast—CYP3A4—blood—acquired immunodeficiency syndrome	0.00013	0.00755	CbGeAlD
Zafirlukast—CYP2D6—blood—acquired immunodeficiency syndrome	0.000128	0.00743	CbGeAlD
Zafirlukast—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000127	0.00734	CbGeAlD
Zafirlukast—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000127	0.00733	CbGeAlD
Zafirlukast—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000122	0.00707	CbGeAlD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000121	0.0309	CbGpPWpGaD
Zafirlukast—CYP2C8—brain—acquired immunodeficiency syndrome	0.000119	0.00692	CbGeAlD
Zafirlukast—ABCG2—brain—acquired immunodeficiency syndrome	0.000116	0.00673	CbGeAlD
Zafirlukast—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.00134	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000114	0.00134	CcSEcCtD
Zafirlukast—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000114	0.00133	CcSEcCtD
Zafirlukast—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000113	0.00133	CcSEcCtD
Zafirlukast—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000113	0.00132	CcSEcCtD
Zafirlukast—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.00132	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000112	0.00132	CcSEcCtD
Zafirlukast—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000112	0.0065	CbGeAlD
Zafirlukast—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000112	0.00131	CcSEcCtD
Zafirlukast—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.00131	CcSEcCtD
Zafirlukast—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000111	0.0013	CcSEcCtD
Zafirlukast—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.0013	CcSEcCtD
Zafirlukast—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.0013	CcSEcCtD
Zafirlukast—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000111	0.0013	CcSEcCtD
Zafirlukast—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000111	0.0013	CcSEcCtD
Zafirlukast—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000111	0.0013	CcSEcCtD
Zafirlukast—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000111	0.0013	CcSEcCtD
Zafirlukast—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000111	0.0013	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.00129	CcSEcCtD
Zafirlukast—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00011	0.00129	CcSEcCtD
Zafirlukast—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00011	0.00129	CcSEcCtD
Zafirlukast—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00011	0.00129	CcSEcCtD
Zafirlukast—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00011	0.00129	CcSEcCtD
Zafirlukast—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00011	0.00129	CcSEcCtD
Zafirlukast—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.00129	CcSEcCtD
Zafirlukast—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.00128	CcSEcCtD
Zafirlukast—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000109	0.00128	CcSEcCtD
Zafirlukast—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000109	0.00127	CcSEcCtD
Zafirlukast—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000109	0.00127	CcSEcCtD
Zafirlukast—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.00126	CcSEcCtD
Zafirlukast—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.00126	CcSEcCtD
Zafirlukast—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.00125	CcSEcCtD
Zafirlukast—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.00125	CcSEcCtD
Zafirlukast—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.00125	CcSEcCtD
Zafirlukast—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.00125	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000106	0.027	CbGpPWpGaD
Zafirlukast—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000106	0.00613	CbGeAlD
Zafirlukast—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.00123	CcSEcCtD
Zafirlukast—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000105	0.00123	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000105	0.00123	CcSEcCtD
Zafirlukast—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.00122	CcSEcCtD
Zafirlukast—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.00122	CcSEcCtD
Zafirlukast—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000104	0.00603	CbGeAlD
Zafirlukast—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.00122	CcSEcCtD
Zafirlukast—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.00121	CcSEcCtD
Zafirlukast—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000104	0.00121	CcSEcCtD
Zafirlukast—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.00121	CcSEcCtD
Zafirlukast—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.00121	CcSEcCtD
Zafirlukast—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000103	0.0012	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000103	0.0012	CcSEcCtD
Zafirlukast—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.0012	CcSEcCtD
Zafirlukast—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000102	0.0012	CcSEcCtD
Zafirlukast—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000102	0.0012	CcSEcCtD
Zafirlukast—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000102	0.00119	CcSEcCtD
Zafirlukast—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000102	0.0059	CbGeAlD
Zafirlukast—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.00119	CcSEcCtD
Zafirlukast—Rash—Didanosine—acquired immunodeficiency syndrome	0.000101	0.00119	CcSEcCtD
Zafirlukast—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.00119	CcSEcCtD
Zafirlukast—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000101	0.00119	CcSEcCtD
Zafirlukast—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000101	0.00119	CcSEcCtD
Zafirlukast—Headache—Didanosine—acquired immunodeficiency syndrome	0.000101	0.00118	CcSEcCtD
Zafirlukast—CYP2E1—brain—acquired immunodeficiency syndrome	0.000101	0.00582	CbGeAlD
Zafirlukast—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.0001	0.00118	CcSEcCtD
Zafirlukast—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.0001	0.00581	CbGeAlD
Zafirlukast—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.00117	CcSEcCtD
Zafirlukast—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.0001	0.00117	CcSEcCtD
Zafirlukast—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	9.98e-05	0.00117	CcSEcCtD
Zafirlukast—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	9.97e-05	0.00117	CcSEcCtD
Zafirlukast—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	9.92e-05	0.00116	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	9.91e-05	0.00116	CcSEcCtD
Zafirlukast—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	9.89e-05	0.00116	CcSEcCtD
Zafirlukast—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	9.88e-05	0.00116	CcSEcCtD
Zafirlukast—Pruritus—Stavudine—acquired immunodeficiency syndrome	9.86e-05	0.00116	CcSEcCtD
Zafirlukast—Asthenia—Abacavir—acquired immunodeficiency syndrome	9.85e-05	0.00115	CcSEcCtD
Zafirlukast—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	9.83e-05	0.00115	CcSEcCtD
Zafirlukast—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	9.83e-05	0.00115	CcSEcCtD
Zafirlukast—Myalgia—Ritonavir—acquired immunodeficiency syndrome	9.83e-05	0.00115	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.73e-05	0.00114	CcSEcCtD
Zafirlukast—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.72e-05	0.00114	CcSEcCtD
Zafirlukast—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.71e-05	0.00114	CcSEcCtD
Zafirlukast—Discomfort—Ritonavir—acquired immunodeficiency syndrome	9.71e-05	0.00114	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.7e-05	0.00114	CcSEcCtD
Zafirlukast—Angioedema—Lamivudine—acquired immunodeficiency syndrome	9.68e-05	0.00114	CcSEcCtD
Zafirlukast—PTGS1—brain—acquired immunodeficiency syndrome	9.68e-05	0.00561	CbGeAlD
Zafirlukast—Pain—Indinavir—acquired immunodeficiency syndrome	9.64e-05	0.00113	CcSEcCtD
Zafirlukast—Insomnia—Efavirenz—acquired immunodeficiency syndrome	9.63e-05	0.00113	CcSEcCtD
Zafirlukast—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.63e-05	0.00113	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	9.59e-05	0.0244	CbGpPWpGaD
Zafirlukast—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.58e-05	0.00112	CcSEcCtD
Zafirlukast—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.58e-05	0.00112	CcSEcCtD
Zafirlukast—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.57e-05	0.00112	CcSEcCtD
Zafirlukast—Malaise—Lamivudine—acquired immunodeficiency syndrome	9.56e-05	0.00112	CcSEcCtD
Zafirlukast—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.54e-05	0.00112	CcSEcCtD
Zafirlukast—Nausea—Didanosine—acquired immunodeficiency syndrome	9.54e-05	0.00112	CcSEcCtD
Zafirlukast—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.46e-05	0.00111	CcSEcCtD
Zafirlukast—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.46e-05	0.00111	CcSEcCtD
Zafirlukast—Oedema—Ritonavir—acquired immunodeficiency syndrome	9.42e-05	0.0011	CcSEcCtD
Zafirlukast—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.4e-05	0.0011	CcSEcCtD
Zafirlukast—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	9.37e-05	0.0011	CcSEcCtD
Zafirlukast—PTGS1—lymph node—acquired immunodeficiency syndrome	9.36e-05	0.00542	CbGeAlD
Zafirlukast—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.34e-05	0.0011	CcSEcCtD
Zafirlukast—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.29e-05	0.00109	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.28e-05	0.00109	CcSEcCtD
Zafirlukast—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.25e-05	0.00108	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	9.24e-05	0.0235	CbGpPWpGaD
Zafirlukast—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.22e-05	0.00108	CcSEcCtD
Zafirlukast—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.22e-05	0.00108	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.21e-05	0.00108	CcSEcCtD
Zafirlukast—Insomnia—Delavirdine—acquired immunodeficiency syndrome	9.21e-05	0.00108	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.19e-05	0.00108	CcSEcCtD
Zafirlukast—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.18e-05	0.00108	CcSEcCtD
Zafirlukast—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.18e-05	0.00108	CcSEcCtD
Zafirlukast—Pain—Efavirenz—acquired immunodeficiency syndrome	9.1e-05	0.00107	CcSEcCtD
Zafirlukast—Rash—Nevirapine—acquired immunodeficiency syndrome	9.1e-05	0.00107	CcSEcCtD
Zafirlukast—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.09e-05	0.00107	CcSEcCtD
Zafirlukast—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.08e-05	0.00106	CcSEcCtD
Zafirlukast—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.07e-05	0.00106	CcSEcCtD
Zafirlukast—Headache—Nevirapine—acquired immunodeficiency syndrome	9.04e-05	0.00106	CcSEcCtD
Zafirlukast—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.00106	CcSEcCtD
Zafirlukast—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.00106	CcSEcCtD
Zafirlukast—Infection—Saquinavir—acquired immunodeficiency syndrome	9.01e-05	0.00106	CcSEcCtD
Zafirlukast—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	8.97e-05	0.00105	CcSEcCtD
Zafirlukast—Urticaria—Indinavir—acquired immunodeficiency syndrome	8.95e-05	0.00105	CcSEcCtD
Zafirlukast—Discomfort—Lamivudine—acquired immunodeficiency syndrome	8.91e-05	0.00104	CcSEcCtD
Zafirlukast—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	8.91e-05	0.00104	CcSEcCtD
Zafirlukast—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	8.91e-05	0.00104	CcSEcCtD
Zafirlukast—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	8.89e-05	0.00104	CcSEcCtD
Zafirlukast—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	8.88e-05	0.00104	CcSEcCtD
Zafirlukast—Vomiting—Stavudine—acquired immunodeficiency syndrome	8.86e-05	0.00104	CcSEcCtD
Zafirlukast—Rash—Nelfinavir—acquired immunodeficiency syndrome	8.82e-05	0.00103	CcSEcCtD
Zafirlukast—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	8.81e-05	0.00103	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	8.79e-05	0.00103	CcSEcCtD
Zafirlukast—Rash—Stavudine—acquired immunodeficiency syndrome	8.79e-05	0.00103	CcSEcCtD
Zafirlukast—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.78e-05	0.00103	CcSEcCtD
Zafirlukast—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.78e-05	0.00103	CcSEcCtD
Zafirlukast—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	8.77e-05	0.00103	CcSEcCtD
Zafirlukast—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.76e-05	0.00103	CcSEcCtD
Zafirlukast—Headache—Stavudine—acquired immunodeficiency syndrome	8.73e-05	0.00102	CcSEcCtD
Zafirlukast—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.73e-05	0.00102	CcSEcCtD
Zafirlukast—Pain—Delavirdine—acquired immunodeficiency syndrome	8.71e-05	0.00102	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.71e-05	0.00102	CcSEcCtD
Zafirlukast—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.69e-05	0.00102	CcSEcCtD
Zafirlukast—Rash—Abacavir—acquired immunodeficiency syndrome	8.66e-05	0.00101	CcSEcCtD
Zafirlukast—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.65e-05	0.00101	CcSEcCtD
Zafirlukast—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.65e-05	0.00101	CcSEcCtD
Zafirlukast—Headache—Abacavir—acquired immunodeficiency syndrome	8.6e-05	0.00101	CcSEcCtD
Zafirlukast—Infection—Lamivudine—acquired immunodeficiency syndrome	8.59e-05	0.00101	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.58e-05	0.00101	CcSEcCtD
Zafirlukast—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.58e-05	0.00101	CcSEcCtD
Zafirlukast—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.57e-05	0.001	CcSEcCtD
Zafirlukast—Insomnia—Ritonavir—acquired immunodeficiency syndrome	8.52e-05	0.000999	CcSEcCtD
Zafirlukast—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.47e-05	0.000993	CcSEcCtD
Zafirlukast—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8.46e-05	0.000991	CcSEcCtD
Zafirlukast—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.42e-05	0.000986	CcSEcCtD
Zafirlukast—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.42e-05	0.000986	CcSEcCtD
Zafirlukast—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.39e-05	0.000984	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.33e-05	0.000976	CcSEcCtD
Zafirlukast—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.31e-05	0.000973	CcSEcCtD
Zafirlukast—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.3e-05	0.000973	CcSEcCtD
Zafirlukast—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.29e-05	0.000972	CcSEcCtD
Zafirlukast—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.29e-05	0.000972	CcSEcCtD
Zafirlukast—Nausea—Stavudine—acquired immunodeficiency syndrome	8.28e-05	0.000971	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.26e-05	0.000968	CcSEcCtD
Zafirlukast—Insomnia—Saquinavir—acquired immunodeficiency syndrome	8.2e-05	0.000961	CcSEcCtD
Zafirlukast—Nausea—Abacavir—acquired immunodeficiency syndrome	8.16e-05	0.000956	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.13e-05	0.000953	CcSEcCtD
Zafirlukast—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.12e-05	0.000952	CcSEcCtD
Zafirlukast—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.09e-05	0.000948	CcSEcCtD
Zafirlukast—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.08e-05	0.000948	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	8.08e-05	0.0206	CbGpPWpGaD
Zafirlukast—Pain—Ritonavir—acquired immunodeficiency syndrome	8.06e-05	0.000944	CcSEcCtD
Zafirlukast—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.05e-05	0.000944	CcSEcCtD
Zafirlukast—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.05e-05	0.000944	CcSEcCtD
Zafirlukast—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.01e-05	0.000939	CcSEcCtD
Zafirlukast—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	7.98e-05	0.000935	CcSEcCtD
Zafirlukast—Pruritus—Indinavir—acquired immunodeficiency syndrome	7.97e-05	0.000934	CcSEcCtD
Zafirlukast—CYP2D6—brain—acquired immunodeficiency syndrome	7.96e-05	0.00461	CbGeAlD
Zafirlukast—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	7.88e-05	0.000924	CcSEcCtD
Zafirlukast—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	7.84e-05	0.000919	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	7.83e-05	0.000917	CcSEcCtD
Zafirlukast—Insomnia—Lamivudine—acquired immunodeficiency syndrome	7.82e-05	0.000917	CcSEcCtD
Zafirlukast—Fatigue—Saquinavir—acquired immunodeficiency syndrome	7.82e-05	0.000916	CcSEcCtD
Zafirlukast—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.76e-05	0.00091	CcSEcCtD
Zafirlukast—Pain—Saquinavir—acquired immunodeficiency syndrome	7.75e-05	0.000909	CcSEcCtD
Zafirlukast—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.71e-05	0.000904	CcSEcCtD
Zafirlukast—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.7e-05	0.000903	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.7e-05	0.000903	CcSEcCtD
Zafirlukast—Rash—Zidovudine—acquired immunodeficiency syndrome	7.64e-05	0.000895	CcSEcCtD
Zafirlukast—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.64e-05	0.000895	CcSEcCtD
Zafirlukast—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.63e-05	0.000895	CcSEcCtD
Zafirlukast—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.61e-05	0.000892	CcSEcCtD
Zafirlukast—Headache—Zidovudine—acquired immunodeficiency syndrome	7.59e-05	0.00089	CcSEcCtD
Zafirlukast—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.53e-05	0.000883	CcSEcCtD
Zafirlukast—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.5e-05	0.00088	CcSEcCtD
Zafirlukast—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.48e-05	0.000877	CcSEcCtD
Zafirlukast—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.47e-05	0.000876	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.47e-05	0.000875	CcSEcCtD
Zafirlukast—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.46e-05	0.000874	CcSEcCtD
Zafirlukast—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.45e-05	0.000873	CcSEcCtD
Zafirlukast—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.45e-05	0.000873	CcSEcCtD
Zafirlukast—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.45e-05	0.000873	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.41e-05	0.000869	CcSEcCtD
Zafirlukast—Pain—Lamivudine—acquired immunodeficiency syndrome	7.4e-05	0.000867	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	7.35e-05	0.0187	CbGpPWpGaD
Zafirlukast—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.31e-05	0.000857	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	7.31e-05	0.0186	CbGpPWpGaD
Zafirlukast—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.28e-05	0.000854	CcSEcCtD
Zafirlukast—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.21e-05	0.000845	CcSEcCtD
Zafirlukast—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.2e-05	0.000844	CcSEcCtD
Zafirlukast—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.2e-05	0.000844	CcSEcCtD
Zafirlukast—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.17e-05	0.00084	CcSEcCtD
Zafirlukast—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.17e-05	0.00084	CcSEcCtD
Zafirlukast—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.16e-05	0.00084	CcSEcCtD
Zafirlukast—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.13e-05	0.000835	CcSEcCtD
Zafirlukast—Rash—Indinavir—acquired immunodeficiency syndrome	7.1e-05	0.000833	CcSEcCtD
Zafirlukast—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.1e-05	0.000832	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.07e-05	0.000829	CcSEcCtD
Zafirlukast—Headache—Indinavir—acquired immunodeficiency syndrome	7.06e-05	0.000827	CcSEcCtD
Zafirlukast—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.04e-05	0.000825	CcSEcCtD
Zafirlukast—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.97e-05	0.000817	CcSEcCtD
Zafirlukast—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	6.94e-05	0.000813	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	6.92e-05	0.0176	CbGpPWpGaD
Zafirlukast—Urticaria—Lamivudine—acquired immunodeficiency syndrome	6.87e-05	0.000805	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	6.84e-05	0.0174	CbGpPWpGaD
Zafirlukast—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	6.84e-05	0.000801	CcSEcCtD
Zafirlukast—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	6.84e-05	0.000801	CcSEcCtD
Zafirlukast—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.77e-05	0.000793	CcSEcCtD
Zafirlukast—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.76e-05	0.000792	CcSEcCtD
Zafirlukast—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.74e-05	0.00079	CcSEcCtD
Zafirlukast—Rash—Efavirenz—acquired immunodeficiency syndrome	6.71e-05	0.000787	CcSEcCtD
Zafirlukast—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.71e-05	0.000786	CcSEcCtD
Zafirlukast—Nausea—Indinavir—acquired immunodeficiency syndrome	6.69e-05	0.000784	CcSEcCtD
Zafirlukast—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.68e-05	0.000783	CcSEcCtD
Zafirlukast—Headache—Efavirenz—acquired immunodeficiency syndrome	6.67e-05	0.000782	CcSEcCtD
Zafirlukast—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.66e-05	0.000781	CcSEcCtD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	6.65e-05	0.0169	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	6.55e-05	0.0167	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	6.51e-05	0.0166	CbGpPWpGaD
Zafirlukast—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.5e-05	0.000762	CcSEcCtD
Zafirlukast—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.48e-05	0.000759	CcSEcCtD
Zafirlukast—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.45e-05	0.000755	CcSEcCtD
Zafirlukast—Rash—Delavirdine—acquired immunodeficiency syndrome	6.42e-05	0.000753	CcSEcCtD
Zafirlukast—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.42e-05	0.000752	CcSEcCtD
Zafirlukast—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.41e-05	0.000752	CcSEcCtD
Zafirlukast—Headache—Delavirdine—acquired immunodeficiency syndrome	6.38e-05	0.000748	CcSEcCtD
Zafirlukast—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.37e-05	0.000747	CcSEcCtD
Zafirlukast—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.32e-05	0.000741	CcSEcCtD
Zafirlukast—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.23e-05	0.00073	CcSEcCtD
Zafirlukast—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.21e-05	0.000727	CcSEcCtD
Zafirlukast—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.2e-05	0.000727	CcSEcCtD
Zafirlukast—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.12e-05	0.000717	CcSEcCtD
Zafirlukast—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.05e-05	0.000709	CcSEcCtD
Zafirlukast—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6e-05	0.000703	CcSEcCtD
Zafirlukast—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.99e-05	0.000702	CcSEcCtD
Zafirlukast—Rash—Ritonavir—acquired immunodeficiency syndrome	5.94e-05	0.000696	CcSEcCtD
Zafirlukast—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.93e-05	0.000695	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	5.93e-05	0.0151	CbGpPWpGaD
Zafirlukast—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.92e-05	0.000694	CcSEcCtD
Zafirlukast—Headache—Ritonavir—acquired immunodeficiency syndrome	5.9e-05	0.000692	CcSEcCtD
Zafirlukast—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.76e-05	0.000676	CcSEcCtD
Zafirlukast—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.72e-05	0.00067	CcSEcCtD
Zafirlukast—Rash—Saquinavir—acquired immunodeficiency syndrome	5.72e-05	0.00067	CcSEcCtD
Zafirlukast—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.71e-05	0.000669	CcSEcCtD
Zafirlukast—Headache—Saquinavir—acquired immunodeficiency syndrome	5.68e-05	0.000666	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	5.6e-05	0.0142	CbGpPWpGaD
Zafirlukast—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.6e-05	0.000656	CcSEcCtD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	5.57e-05	0.0142	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	5.57e-05	0.0142	CbGpPWpGaD
Zafirlukast—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.5e-05	0.000645	CcSEcCtD
Zafirlukast—Rash—Lamivudine—acquired immunodeficiency syndrome	5.45e-05	0.000639	CcSEcCtD
Zafirlukast—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.45e-05	0.000639	CcSEcCtD
Zafirlukast—Headache—Lamivudine—acquired immunodeficiency syndrome	5.42e-05	0.000635	CcSEcCtD
Zafirlukast—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.39e-05	0.000631	CcSEcCtD
Zafirlukast—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.14e-05	0.000602	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	5.06e-05	0.0129	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	4.99e-05	0.0127	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	4.8e-05	0.0122	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	4.74e-05	0.0121	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	4.69e-05	0.0119	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	4.69e-05	0.0119	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	4.54e-05	0.0116	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	4.51e-05	0.0115	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	4.51e-05	0.0115	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	4.46e-05	0.0113	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	4.24e-05	0.0108	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	4.24e-05	0.0108	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	4.24e-05	0.0108	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	4.15e-05	0.0106	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	4.11e-05	0.0105	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	4.04e-05	0.0103	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	3.86e-05	0.00983	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	3.86e-05	0.00983	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.82e-05	0.00972	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.75e-05	0.00954	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	3.52e-05	0.00896	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	3.46e-05	0.0088	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	3.23e-05	0.00822	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.13e-05	0.00796	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.09e-05	0.00786	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	2.94e-05	0.00749	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	2.94e-05	0.00749	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	2.94e-05	0.00748	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.91e-05	0.0074	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	2.87e-05	0.00731	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	2.84e-05	0.00723	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.8e-05	0.00713	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.65e-05	0.00674	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.6e-05	0.00661	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.56e-05	0.00652	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.55e-05	0.00649	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.45e-05	0.00623	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.45e-05	0.00623	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.4e-05	0.0061	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.4e-05	0.0061	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.32e-05	0.00589	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.24e-05	0.00569	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.22e-05	0.00564	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.18e-05	0.00554	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.18e-05	0.00554	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.02e-05	0.00513	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.92e-05	0.00488	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.00464	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.8e-05	0.00457	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.78e-05	0.00452	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.77e-05	0.0045	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.75e-05	0.00446	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	1.75e-05	0.00445	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.7e-05	0.00432	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.7e-05	0.00432	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.66e-05	0.00423	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.66e-05	0.00423	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.66e-05	0.00422	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.00418	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.00415	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.61e-05	0.00409	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	1.6e-05	0.00406	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.54e-05	0.00391	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.51e-05	0.00385	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.51e-05	0.00384	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.51e-05	0.00384	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.0038	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.37e-05	0.00348	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.29e-05	0.00327	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.29e-05	0.00327	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.26e-05	0.00322	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.25e-05	0.00317	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.24e-05	0.00315	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.21e-05	0.00309	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	1.21e-05	0.00307	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.15e-05	0.00292	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.0029	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.13e-05	0.00288	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.1e-05	0.00281	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	1.07e-05	0.00273	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.05e-05	0.00267	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	1.04e-05	0.00266	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.03e-05	0.00263	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.03e-05	0.00263	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.01e-05	0.00256	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	1e-05	0.00255	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.79e-06	0.00249	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.64e-06	0.00245	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.5e-06	0.00242	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.49e-06	0.00241	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.92e-06	0.00227	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.92e-06	0.00227	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	8.88e-06	0.00226	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.82e-06	0.00224	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.63e-06	0.00219	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.61e-06	0.00219	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	8.54e-06	0.00217	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	8.34e-06	0.00212	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	7.8e-06	0.00198	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	7.8e-06	0.00198	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	7.5e-06	0.00191	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.78e-06	0.00173	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.68e-06	0.0017	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.58e-06	0.00168	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	6.48e-06	0.00165	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	6.38e-06	0.00162	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.11e-06	0.00156	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.98e-06	0.00152	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	5.79e-06	0.00147	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	5.51e-06	0.0014	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	5.32e-06	0.00135	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	5.28e-06	0.00134	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.1e-06	0.0013	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.07e-06	0.00129	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	4.92e-06	0.00125	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	4.53e-06	0.00115	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	4.51e-06	0.00115	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	4.49e-06	0.00114	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.93e-06	0.001	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.89e-06	0.00099	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.83e-06	0.000976	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.53e-06	0.000899	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.51e-06	0.000894	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	3.48e-06	0.000886	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.99e-06	0.000762	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.96e-06	0.000753	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.54e-06	0.000646	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.27e-06	0.000577	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.08e-06	0.000528	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.07e-06	0.000526	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	1.82e-06	0.000464	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.77e-06	0.000449	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	1.75e-06	0.000445	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	1.31e-06	0.000333	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	1.13e-06	0.000288	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	1.01e-06	0.000257	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	9.28e-07	0.000236	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	9.2e-07	0.000234	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	7.86e-07	0.0002	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	6.07e-07	0.000154	CbGpPWpGaD
